Busulfan Versus Hydroxyurea in the Treatment of Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference11 articles.
1. Treatment of polycythaemia vera by radiophosphorus or busulphan: A randomized trial.
2. Treatment of Polycythemia Vera: Use of 32P Alone or in Combination With Maintenance Therapy Using Hydroxyurea in 461 Patients Greater Than 65 Years of Age
3. Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil Therapy
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-06-26
2. Binding Sites of Anticancer Drugs on Human Serum Albumin (HSA): A Review;Protein & Peptide Letters;2022-08
3. Recent Progress in Interferon Therapy for Myeloid Malignancies;Frontiers in Oncology;2021-10-29
4. Polycythemia vera: historical oversights, diagnostic details, and therapeutic views;Leukemia;2021-09-03
5. Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea;Blood Cancer Journal;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3